This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
04/28/16 - 3:59:56 PM ET (BATS BZX Real-time Price)
Div Yield: --
AEGR Day's Range
AEGR 52 Week Range
AEGR Business Summary
Aegerion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapies for patients with debilitating rare diseases in the United States.View AEGR
Aegerion Pharmaceuticals Inc - AEGR - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates Aegerion Pharmaceuticals Inc as a
Sell with a ratings score of D.
Report Snippet: We rate AEGERION PHARMACEUTICALS INC (AEGR) a SELL. This is driven by several weaknesses, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the stocks we cover. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, weak operating cash flow, generally high debt management risk and generally disappointing historical performance in the stock itself.